What are the implications of a left bundle branch block (LBBB)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Left bundle branch block (LBBB) is a significant cardiac conduction abnormality that can lead to impaired electromechanical coupling, reduced ventricular systolic function, and increased risk of heart failure and mortality, particularly in patients with QRS duration ≥150 milliseconds. The implications of LBBB are far-reaching, and its presence can mask signs of myocardial infarction on electrocardiogram (ECG) and may indicate underlying cardiac disease [ 1 ]. LBBB itself doesn't require specific treatment, but it's essential to identify and address any underlying cause such as coronary artery disease, hypertension, cardiomyopathy, or valvular heart disease.

Key Considerations

  • LBBB can cause regional mechanical delay within the left ventricle, resulting in reduced ventricular systolic function, altered myocardial metabolism, functional mitral regurgitation, and adverse remodeling with ventricular dilatation [ 1 ].
  • The presence of LBBB with QRS duration ≥150 milliseconds is a significant predictor of worsening heart failure, sudden cardiac death, and total death [ 1 ].
  • Cardiac resynchronization therapy (CRT) may be beneficial in patients with heart failure and LBBB with QRS duration ≥150 milliseconds to improve cardiac function and reduce mortality [ 1 ].
  • Patients with LBBB should undergo cardiac evaluation, including echocardiography to assess for structural heart disease and possible stress testing to evaluate for coronary artery disease.

Management and Treatment

  • CRT is recommended as a Class I indication for patients with LBBB and QRS duration ≥150 milliseconds, as it has been shown to improve ventricular systolic function, reduce metabolic costs, ameliorate functional mitral regurgitation, and induce favorable remodeling with reduction of cardiac chamber dimensions [ 1 ].
  • The differential classification of CRT benefit based on QRS duration is supported by multiple analyses, which have consistently demonstrated that a significant clinical benefit from CRT is greatest among patients with QRS duration ≥150 milliseconds [ 1 ].

From the Research

Implications of Left Bundle Branch Block (LBBB)

The implications of LBBB can be significant, particularly in patients with heart failure. Some key points to consider include:

  • LBBB may be due to conduction system degeneration or a reflection of myocardial pathology, and can also develop following aortic valve disease or cardiac procedures 2
  • Patients with heart failure with reduced ejection fraction and LBBB may respond positively to cardiac resynchronization therapy (CRT) 2
  • LBBB can lead to severe left ventricular dyssynchrony, resulting in acute heart failure, particularly in cases where the block is acceleration-dependent 3
  • CRT has been shown to improve hemodynamics in patients with heart failure and LBBB by resynchronizing left ventricular dyssynchrony 3

Cardiac Resynchronization Therapy (CRT) Options

Several options are available for delivering CRT, including:

  • Lead placement via the coronary sinus, which is the mainstay approach of CRT 2
  • Left bundle branch pacing (LBBP), which has been suggested as an alternative means to deliver CRT 4, 5
  • His bundle pacing (HBP), which has been compared to LBBP and biventricular pacing (BVP) in terms of on-treatment outcomes 5
  • Biventricular pacing (BVP), which has been shown to be less effective than LBBP and HBP in improving left ventricular ejection fraction (LVEF) and New York Heart Association (NYHA) class 5

Outcomes of LBBP

The outcomes of LBBP have been studied in several patient populations, including:

  • Patients with heart failure with reduced ejection fraction and LBBB, who have been shown to respond positively to LBBP 4, 5
  • Patients with mildly reduced and preserved left ventricular ejection fraction, who have been shown to experience improvements in cardiac function and remodelling with LBBP 6
  • Patients with nonischemic cardiomyopathy, who have been shown to experience significant improvements in LVEF and NYHA class with LBBP 5, 6

Patient Selection for CRT

Patient selection for CRT is critical, and may involve:

  • Evaluation for left ventricular dyssynchrony during exercise, particularly in patients with acceleration-dependent LBBB 3
  • Assessment of LVEF and NYHA class, as well as other clinical and echocardiographic parameters 4, 5, 6
  • Consideration of alternative CRT options, such as LBBP and HBP, in patients who may not be suitable for traditional BVP 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.